AstraZeneca
  1. Companies
  2. AstraZeneca
  3. Products
  4. Model AZD2693 - Phase I - NASH

Model AZD2693 - Phase I -NASH

SHARE

Mechanism: NASH resolution; Area under investigation: NASH; Date commenced phase: Q4 2019; Estimated Filing Acceptance: US: EU: Japan: China. Additional information. Molecule size: Small molecule; Status change.

Most popular related searches